Substance Name: Cemiplimab [USAN]
RN: 1801342-60-8
UNII: 6QVL057INT
Note
- Human monoclonal antibody against programmed cell death 1 protein (PD-1) for the treatment of metastatic or unresectable cutaneous squamous cell carcinoma (CSCC).
Molecular Formula
- C6380-H9808-N1688-O2000-S44
Classification Codes
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Treatment of Cancer
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Cemiplimab [USAN]
Synonyms
- Cemiplimab
- REGN2810
- UNII-6QVL057INT
Systematic Name
- Immunoglobulin G4, anti-(human programmed cell death protein 1) (human monoclonal REGN2810 heavy chain), disulfide with human monoclonal REGN2810 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 1801342-60-8
FDA UNII
- 6QVL057INT
System Generated Number
- 1801342608